Author Correction: An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo Authors: Huiping Shuai, Jingxin Qiao, Chaemin Yoon, Guo Zhang, Yuxin Hou, Xiaoyan Xia, Lei Wang, Xinyue Deng, Yifei Wang, Qingquan Li, Lianzhao Du, Yuanchen Liu, Minmin Zhou, Hoi Ting Wong, Jiaheng Hu, Huan Liu, Bingjie Hu, Dong Wang, Jingyi Su, Yuying Pan, Yongtao Ye, Yan Chen, Zhen Fang, Ziyi Xia, Yue Chai, Jialu Shi, Yang Wang, Tianrenzheng Zhu, Honglei Zhang, Shuofeng Yuan, Jie Zhou, Jasper Fuk-Woo Chan, Kwok-Yung Yuen, Chunfu Xu, Jian Lei, Shengyong Yang, Hin Chu Published: 2025 Correction to: Nature Communications 10.1038/s41467-025-60832-z, published online 16 July 2025 In the version of the article initially published, the “DMSO, TMP1” image in Fig. 5d was incorrect and has now been replaced in the HTML and PDF versions of the article. The original Fig. 5 is available as Supplementary information for comparison. Supplementary information Original, uncorrected Fig. 5 Footnotes These authors contributed equally: Huiping Shuai, Jingxin Qiao, Chaemin Yoon, Guo Zhang, Yuxin Hou, Xiaoyan Xia, Lei Wang, Xinyue Deng. Contributor Information Jian Lei, Email: leijian@scu.edu.cn. Shengyong Yang, Email: yangsy@scu.edu.cn. Hin Chu, Email: hinchu@hku.hk. Supplementary information The online version contains supplementary material available at 10.1038/s41467-025-67654-z. Associated Data Supplementary Materials Original, uncorrected Fig. 5